- Home
- COCH vs GBIO Comparison
COCH vs GBIO Comparison
Compare COCH & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- GBIO
- Stock Information
- Founded
- COCH 1995
- GBIO 2016
- Country
- COCH United States
- GBIO United States
- Employees
- COCH N/A
- GBIO N/A
- Industry
- COCH Blank Checks
- GBIO Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- GBIO Health Care
- Exchange
- COCH Nasdaq
- GBIO Nasdaq
- Market Cap
- COCH 31.6M
- GBIO 29.2M
- IPO Year
- COCH N/A
- GBIO 2020
- Fundamental
- Price
- COCH $1.62
- GBIO $0.41
- Analyst Decision
- COCH Strong Buy
- GBIO Strong Buy
- Analyst Count
- COCH 2
- GBIO 4
- Target Price
- COCH $9.25
- GBIO $7.33
- AVG Volume (30 Days)
- COCH 30.8K
- GBIO 2.0M
- Earning Date
- COCH 08-11-2025
- GBIO 08-06-2025
- Dividend Yield
- COCH N/A
- GBIO N/A
- EPS Growth
- COCH N/A
- GBIO N/A
- EPS
- COCH N/A
- GBIO N/A
- Revenue
- COCH $212,000.00
- GBIO $24,556,000.00
- Revenue This Year
- COCH $5.93
- GBIO N/A
- Revenue Next Year
- COCH $17.69
- GBIO N/A
- P/E Ratio
- COCH N/A
- GBIO N/A
- Revenue Growth
- COCH N/A
- GBIO 146.47
- 52 Week Low
- COCH $1.21
- GBIO $0.30
- 52 Week High
- COCH $3.99
- GBIO $3.65
- Technical
- Relative Strength Index (RSI)
- COCH 58.19
- GBIO 50.87
- Support Level
- COCH $1.56
- GBIO $0.32
- Resistance Level
- COCH $1.80
- GBIO $0.59
- Average True Range (ATR)
- COCH 0.12
- GBIO 0.05
- MACD
- COCH 0.02
- GBIO 0.02
- Stochastic Oscillator
- COCH 60.00
- GBIO 34.16
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.